SCHEMBL16634461

SCHEMBL16634461

O=[N+]([O-])c1ccc(S(=O)(=O)Nc2nc3ccccc3s2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 2/20 0.70
▸ MEN1 O00255 8/20 0.69
▸ KMT2A Q03164 8/20 0.69
▸ ALDH1A1 P00352 6/20 0.69
▸ PKM P14618 1/20 0.67
▸ CYP3A4 P08684 1/20 0.66
▸ CYP2D6 P10635 1/20 0.66
▸ CYP2C9 P11712 1/20 0.66
▸ ALOX15 P16050 1/20 0.66
▸ CYP2C19 P33261 1/20 0.66
▸ NPC1 O15118 1/20 0.62
▸ MMP13 P45452 2/20 0.60
▸ SCD O00767 1/20 0.60
▸ MAPT P10636 1/20 0.59
▸ THRB P10828 1/20 0.59
▸ POLB P06746 1/20 0.59
▸ FSCN1 Q16658 1/20 0.58
▸ STAT3 P40763 1/20 0.58
▸ APP P05067 1/20 0.56
▸ MMP2 P08253 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13265866 0.86 MEN1 (0.61) PTPN1MEN1KMT2AALDH1A1PKM
SCHEMBL617744 0.84 ALDH1A1 (0.72) MEN1KMT2AALDH1A1PKMALOX15
SCHEMBL16634465 0.82 ALDH1A1 (0.70) MEN1KMT2AALDH1A1CYP2C9ALOX15
SCHEMBL19771115 0.82 ALDH1A1 (0.74) PTPN1MEN1KMT2AALDH1A1PKM
SCHEMBL13265852 0.82 MEN1 (0.65) PTPN1MEN1KMT2AALDH1A1PKM
SCHEMBL28235537 0.82 MEN1 (1.00) MEN1KMT2AALDH1A1CYP3A4CYP2D6
SCHEMBL16562250 0.80 PTPN1 (0.79) PTPN1MEN1KMT2AALDH1A1PKM
SCHEMBL3490813 0.80 ALDH1A1 (1.00) MEN1KMT2AALDH1A1CYP3A4CYP2D6
SCHEMBL16554007 0.79 ALDH1A1 (0.65) MEN1KMT2AALDH1A1ALOX15STAT3
SCHEMBL13265853 0.76 MEN1 (0.63) PTPN1MEN1KMT2AALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3054936-B1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS EASTERN VIRGINIA MEDICAL SCHOOL (US) 2023-10-18 — — EP disclosed
US-11274077-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase EASTERN VIRGINIA MEDICAL SCHOOL (US) 2022-03-15 — — US disclosed
US-20200392077-A1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO)BENZENESULFONAMIDE DERIVATIVES AS POTENT AND SELECTIVE INHIBITORS OF 12-LIPOXYGENASE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-12-17 — — US disclosed
US-10752581-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase EASTERN VIRGINIA MEDICAL SCHOOL (US) 2020-08-25 — — US disclosed
US-20190276395-A1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO)BENZENESULFONAMIDE DERIVATIVES AS POTENT AND SELECTIVE INHIBITORS OF 12-LIPOXYGENASE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2019-09-12 — — US disclosed
US-10266488-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase EASTERN VIRGINIA MEDICAL SCHOOL (US) 2019-04-23 — — US disclosed
US-20170001955-A1 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase THOMAS JEFFERSON UNIVERSITY 2017-01-05 — — US disclosed
EP-3054936-A1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS Eastern Virginia Medical School (US) 2016-08-17 — — EP disclosed
WO-2015054662-A1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS EASTERN VIRGINIA MEDICAL SCHOOL (US) 2015-04-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10266488-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase ALOX12, ALOX15, ALOX15B PTPN1 3823/4885MEN1 3555/4885KMT2A 3941/4885
US-20200392077-A1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO)BENZENESULFONAMIDE DERIVATIVES AS POTENT AND SELECTIVE INHIBITORS OF 12-LIPOXYGENASE ALOX12, ALOX15, ALOX15B PTPN1 3823/4885MEN1 3555/4885KMT2A 3941/4885
US-11274077-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase ALOX12, ALOX15, ALOX15B PTPN1 3823/4885MEN1 3555/4885KMT2A 3941/4885
US-20190276395-A1 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO)BENZENESULFONAMIDE DERIVATIVES AS POTENT AND SELECTIVE INHIBITORS OF 12-LIPOXYGENASE ALOX12, ALOX15, ALOX15B PTPN1 3823/4885MEN1 3555/4885KMT2A 3941/4885
US-10752581-B2 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase ALOX12, ALOX15, ALOX15B PTPN1 3823/4885MEN1 3555/4885KMT2A 3941/4885
US-20170001955-A1 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase ALOX12, ALOX15, ALOX15B PTPN1 3823/4885MEN1 3555/4885KMT2A 3941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback